Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | MC4R | P32245 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.45 |
| ▸ | CDC7 | O00311 | 2/20 | 0.45 |
| ▸ | DBF4 | Q9UBU7 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1141274 | 0.98 | GAA (0.56) | GAAKMT2AHSD17B10MAPTNPC1 | |
| Potassium SCHEMBL7063916 | 0.96 | GAA (0.55) | GAAKMT2AHSD17B10MAPTNPC1 | |
| Lithium SCHEMBL7065338 | 0.96 | GAA (0.55) | GAAKMT2AHSD17B10MAPTNPC1 | |
| SCHEMBL14650156 | 0.90 | ALDH1A1 (0.51) | GAAKMT2AHSD17B10MAPTNPC1 | |
| SCHEMBL6206616 | 0.90 | ALDH1A1 (0.54) | GAAKMT2AHSD17B10MAPTNPC1 | |
| SCHEMBL13359464 | 0.88 | GAA (0.49) | GAAKMT2AHSD17B10MAPTNPC1 | |
| SCHEMBL10925924 | 0.88 | MAPT (0.56) | GAAKMT2AHSD17B10MAPTNPC1 | |
| Protiofate SCHEMBL871311 | 0.81 | MAPT (0.50) | GAAKMT2AHSD17B10MAPTALDH1A1 | |
| SCHEMBL11099233 | 0.80 | ALDH1A1 (0.48) | GAAKMT2AHSD17B10MAPTNPC1 | |
| SCHEMBL15210472 | 0.80 | MAPT (0.61) | GAAKMT2AHSD17B10MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6608164-B2 | Diaryl carbonate reacted with dihydroxy aromatic compounds in the presence of a transesterification catalyst; furan diol derivative is dimethyl 3,4-dihydroxy-2,5-furandiacarboxylate disodium salt | GENERAL ELECTRIC COMPANY | 2003-08-19 | — | — | US | claimed |
| US-20030114633-A1 | Salts of heterocyclic diols as catalysts for melt polycarbonate | GENERAL ELECTRIC COMPANY | 2003-06-19 | — | — | US | claimed |
| EP-3246329-B1 | METHOD FOR THE PREPARATION OF A MONOMER BASED ON THIOPHENE OF FORMULA (2,3-DIHYDROTHIENO [3,4-B][1,4]DIOXIN-2-YL)METHANOL AND THE MONOMER PREPARED IN THIS MANNER | CENTRUM ORGANICKE CHEMIE S R O (CZ) | 2018-05-09 | — | — | EP | disclosed |
| EP-3246329-A1 | METHOD FOR THE PREPARATION OF A MONOMER BASED ON THIOPHENE OF FORMULA (2,3-DIHYDROTHIENO [3,4-B][1,4]DIOXIN-2-YL)METHANOL AND THE MONOMER PREPARED IN THIS MANNER | Centrum organické chemie s.r.o. (CZ) | 2017-11-22 | — | — | EP | disclosed |
| CN-104497006-A | Preparation method for 3,4-ethylenedioxythiophene | CHEER FINE PHARMACEUTICAL ANHUI CO LTD | 2015-04-08 | — | — | CN | disclosed |
| EP-1209531-B1 | Toner compositions comprising vinyl resin and poly (3,4-ethylenedioxythiophene) | XEROX CORP (US) | 2012-01-11 | — | — | EP | disclosed |
| US-7708908-B2 | Carboxylic acid-modified EDOT for bioconjugation | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-05-04 | — | — | US | disclosed |
| WO-2008140159-A1 | PROCESS FOR PREPARING ORGANIC SILICON MONOMER | SEHYUN C.M.T. CO., LTD. (KR) | 2008-11-20 | — | — | WO | disclosed |
| US-20080224099-A1 | CARBOXYLIC ACID-MODIFIED EDOT FOR BIOCONJUGATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2008-09-18 | — | — | US | disclosed |
| WO-2008106194-A1 | CARBOXYLIC ACID-MODIFIED EDOT FOR BIOCONJUGATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-09-04 | — | — | WO | disclosed |
| EP-1209532-B1 | Toner compositions comprising polythiophenes | XEROX CORP (US) | 2006-11-15 | — | — | EP | disclosed |
| US-6569591-B2 | Generating electrostatic latent image on imaging member, developing by contacting with charged toner particles comprising resin and optional colorant and coated with polythiophene | XEROX CORPORATION | 2003-05-27 | — | — | US | disclosed |
| US-20030059702-A1 | Toner compositions comprising polythiophenes | XEROX CORPORATION | 2003-03-27 | — | — | US | disclosed |
| US-6503678-B1 | Toner particles having coated thereon a polythiophene doped with anions such as benzene sulfonate | XEROX CORPORATION | 2003-01-07 | — | — | US | disclosed |
| US-6439711-B1 | Ballistic aerosol marking process employing marking material comprising polyester resin and poly (3,4-ethylenedioxythiophene) | XEROX CORPORATION | 2002-08-27 | — | — | US | disclosed |
| EP-1209533-A2 | Process for controlling triboelectric charging | Xerox Corporation (US) | 2002-05-29 | — | — | EP | disclosed |
| EP-1209532-A2 | Toner compositions comprising polythiophenes | Xerox Corporation (US) | 2002-05-29 | — | — | EP | disclosed |
| EP-1209531-A1 | Toner compositions comprising vinyl resin and poly (3,4-ethylenedioxythiophene) | Xerox Corporation (US) | 2002-05-29 | — | — | EP | disclosed |
| US-6383561-B1 | TONER PARTICLES PREPARED BY EMULSION AGGREGATION FORM PROPELLANT STREAM; INK JET PRINTING | XEROX CORPORATION | 2002-05-07 | — | — | US | disclosed |
| US-6365318-B1 | OXIDATIVE POLYMERIZATION OF PYRROLE OR THIOPHENE MONOMERS IN DISPERSION WITH TONER PARTICLES; SUBSEQUENT CHARGING TO NEGATIVE OR POSITIVE POLARITY | XEROX CORPORATION | 2002-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080224099-A1 | CARBOXYLIC ACID-MODIFIED EDOT FOR BIOCONJUGATION | BCAT1, SLC27A1, ACP1 | GAA 3224/4885KMT2A 2505/4885HSD17B10 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.